Publications by authors named "Yu-Tung Hsieh"

Background: Dysregulated long noncoding RNA (lncRNA) expression with increased apoptosis has been demonstrated in systemic lupus erythematosus (SLE) patients with alveolar hemorrhage (AH). SNHG16, a lncRNA, can enhance pulmonary inflammation by sponging microRNAs, and upregulate toll-like receptor 4 (TLR4) expression via stabilizing its mRNAs. TRAF6, a TLR4 downstream signal transducer, can induce autophagy and NETosis formation.

View Article and Find Full Text PDF

Background: Increasing evidences have suggested an important role of microRNAs (miRNAs) in regulating cell death processes including NETosis and apoptosis. Dysregulated expression of miRNAs and increased formation of neutrophil extracellular traps (NETs) and apoptosis participate in autoimmune-mediated diffuse alveolar hemorrhage (DAH), mostly associated with pulmonary capillaritis in systemic lupus erythematosus (SLE) patients. In particular, besides the inhibition of apoptosis, miR-146a can control innate and acquired immune responses, and regulate the toll-like receptor pathway through targeting TRAF6 to reduce the expression of pro-inflammatory cytokines/chemokines like IL-8, a NETosis inducer.

View Article and Find Full Text PDF

Diffuse alveolar hemorrhage (DAH) in systemic lupus erythematosus (SLE) is associated with significant mortality, requiring a thorough understanding of its complex mechanisms to develop novel therapeutics for disease control. Activated p53-dependent apoptosis with dysregulated long non-coding RNA (lncRNA) expression is involved in the SLE pathogenesis and correlated with clinical activity. We examined the expression of apoptosis-related p53-dependent lncRNA, including H19, HOTAIR and lincRNA-p21 in SLE-associated DAH patients.

View Article and Find Full Text PDF
Article Synopsis
  • Accelerated cell death in lupus nephritis is linked to dysregulated long noncoding RNAs, particularly lincRNA-p21, which was studied using patient samples, cell lines, and mouse models.
  • Higher levels of lincRNA-p21 were found in lupus nephritis patients' mononuclear and urine cells, correlating with disease activity, while lower levels of miR-181a were observed.
  • Manipulating lincRNA-p21 through CRISPR interference reduced apoptosis and increased miR-181a, suggesting that lincRNA-p21 could serve as a potential diagnostic marker and therapeutic target for lupus nephritis.
View Article and Find Full Text PDF